NuVasive (NASDAQ:NUVA) shares look quite attractive to Piper Jaffray, who says that it would be an aggressive buyer at or below $15. The firm maintains its Overweight rating following the firm’s announcement a third quarter shortfall.
Safeway (NYSE:SWY) sees its Outperform rating at Cowen reiterated prior to its third quarter earnings results coming next week. The analyst thinks its launch of “Just for U” should restart volume growth and that its non-grocery units including its gift cards segment should hold their material value.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) should benefit from next week’s NACF conference, says Brean Murray, calling the event the first of multiple upcoming catalysts for the company as it anticipates a comprehensive presentation on its cystic fibrosis drug and the likelihood of a successful Phase 3 outcome. Shares are rated Buy and have a price target of $69.
Global Payments (NYSE:GPN) is still one of their best ideas, says Baird, pointing to its potential upside to estimates, historically low valuation, and the anticipation of a return to normalized earnings growth in 2014. Shares are rated Outperform and have a price target of $52.
Tyco International’s (NYSE:TYC) risk/reward is still favorable given its anticipated EBITDA growth, thinks UBS, adding that shares might still be had at a substantial premium. Currently, they are rated Buy with their price target reduced to $32 post-separation.
Don’t Miss: Here’s a New Treatment for Muscular Dystrophy.
Read the original article from The Cheat Sheet
